Pfizer offers AU$100 million for Australian company that developed COVID-19 cough diagnostic app
Biopharmaceutical large Pfizer has provided AU$100 million (US$74.43 million) to amass Australian firm ResApp, which has developed a cellular app ...
Tag: developed
30% of COVID Patients in Study Developed ‘Long COVID’
About 30% of COVID-19 sufferers developed the situation often called lengthy COVID, UCLA researchers stated in a research printed in ...
New skin microbiopsy device developed
UQ microbiopsy deal may change the best way pores and skin circumstances are identified: A pores and skin microbiopsy system developed ...
Welcome to Cipillss. We bring you the most reliable medical news written by our expert editors.
